New FDA-approved test first to detect HIV antigen, antibodies Roche implements risk-mitigation plan for taspoglutide Ferring launches Lysteda Novartis’ Tasigna receives nod from FDA Benlysta could become first lupus treatment in 50 years Clinical trial for Merck KGaA's cancer vaccine continues Study: Celebrex less likely to cause GI issues than other NSAIDs Abbott, Neurocrine Biosciences to commercialize elagolix Patient enrollment complete for lung cancer treatment trial Horizon: Lodotra reduces RA symptoms in patients in trial First Previous 190 191 192 193 194 Next Last
